Cost-effectiveness of brief cognitive behaviour therapy versus treatment as usual in recurrent deliberate self-harm: a decision-making approach
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Background. Deliberate self-harm can be costly, in terms of treatment and subsequent suicide. Any intervention that reduces episodes of self-harm might therefore have a major impact on the costs incurred by service providers and the productivity losses due to illness or premature death. Method. Four hundred and eighty patients with a history of recurrent deliberate self-harm were randomized to manual-assisted cognitive behaviour therapy (MACT) or treatment as usual. Economic data were collected from patients at baseline, 6 and 12 months, and these data were complete for 397 patients. Incremental cost-effectiveness was explored using the primary outcome measure, proportion of patients having a repeat episode of deliberate self-harm, and quality of life. The uncertainty surrounding costs and effects was represented using cost-effectiveness acceptability curves. Results. Differences in total cost per patient were statistically significant at 6 months in favour of MACT (−£897, 95% CI −1747 to −48, P=0·04), but these differences did not remain significant at 12 months (−£838, 95% CI −2142 to 466, P=0·21). Nevertheless, exploration of the uncertainty surrounding these estimates suggests there is >90% probability that MACT is a more cost-effective strategy for reducing the recurrence of deliberate self-harm in this population over 1 year than treatment as usual. The results for quality of life were not conclusive. Conclusion. Cost-effectiveness acceptability curves demonstrate that, based on the evidence currently available, to reject MACT on traditional grounds of statistical significance and to continue funding current practice has <10% chance of being the correct decision in terms of cost-effectiveness.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
EuroQol: the current state of play
Brooks, R. (1996) · Health Policy · doi:10.1016/0168-8510(96)00822-6 · Cited by 5,815
The measurement of pessimism: the hopelessness scale
Beck, A. T., Weissman, A., Lester, D., & Trexler, L. (1974) · Journal of Consulting and Clinical Psychology · doi:10.1037/h0037562 · Cited by 5,494 · cited 2×
“Multiple regression was used to adjust for pre-specified baseline characteristics including baseline cost, gender, age at randomization, living situation (alone versus with others), centre, parasuicide risk score (Kreitman & Foster, 1991), Beck hopelessness score (Beck et al. 1974) and personality status (disorder ver…”
BackgroundMethodStatistics notes: Absence of evidence is not evidence of absence
Altman, D. G., & Bland, J. M. (1995) · BMJ · doi:10.1136/bmj.311.7003.485 · Cited by 1,946
A rational framework for decision making by the National Institute for Clinical Excellence (NICE)
Claxton, K., Sculpher, M., & Drummond, M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09832-x · Cited by 456 · cited 3×
“However, such traditions are being increasingly criticized as irrelevant in a decision-making context (Claxton, 1999; Claxton et al. 2002).”
BackgroundA practical guide for calculating indirect costs of disease
Koopmanschap, M. A., & Rutten, F. F. H. (1996) · PharmacoEconomics · doi:10.2165/00019053-199610050-00003 · Cited by 358
TYRER, P., THOMPSON, S., SCHMIDT, U., JONES, V., KNAPP, M., DAVIDSON, K., CATALAN, J., AIRLIE, J., BAXTER, S., BYFORD, S., et al. (2003) · Psychological Medicine · doi:10.1017/s0033291703008171 · Cited by 190
Self-citation
Cited by
Cost‐effectiveness acceptability curves – facts, fallacies and frequently asked questions
Fenwick, E., O'Brien, B. J., & Briggs, A. (2004) · Health Economics · doi:10.1002/hec.903 · Cited by 943
Mindfulness-based cognitive therapy to prevent relapse in recurrent depression.
Kuyken, W., Byford, S., Taylor, R. S., Watkins, E., Holden, E., White, K., Barrett, B., Byng, R., Evans, A., Mullan, E., et al. (2008) · Journal of Consulting and Clinical Psychology · doi:10.1037/a0013786 · Cited by 770
Self-citationA guide to cost-effectiveness acceptability curves
Fenwick, E., & Byford, S. (2005) · British Journal of Psychiatry · doi:10.1192/bjp.187.2.106 · Cited by 420
Self-citationWeatherly, H., Drummond, M., Claxton, K., Cookson, R., Ferguson, B., Godfrey, C., Rice, N., Sculpher, M., & Sowden, A. (2009) · Health Policy · doi:10.1016/j.healthpol.2009.07.012 · Cited by 321
Brazier, J., Connell, J., Papaioannou, D., Mukuria, C., Mulhern, B., Peasgood, T., Lloyd Jones, M., Paisley, S., O’Cathain, A., Barkham, M., et al. (2014) · Health Technology Assessment · doi:10.3310/hta18340 · Cited by 280
Self-citation
Metadata
- Authors
- BYFORD, S., KNAPP, M., GREENSHIELDS, J., UKOUMUNNE, O. C., JONES, V., THOMPSON, S., TYRER, P., SCHMIDT, U., DAVIDSON, K., & ( POPMACT GROUP)
- Venue
- Psychological Medicine
- Publisher
- Cambridge University Press (CUP)
- Published
- 2003-07-31
- Volume
- 33
- Issue
- 6
- Pages
- 977-986
- ISSN
- 0033-2917 (ISSN-L)
- 1469-8978
- OpenAlex
- W2012629120
- Cited by
- 85
- References
- 6
- FWCI
- 5.53
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Cost-effectiveness of brief cognitive behaviour therapy versus treatment as usual in recurrent deliberate self-harm: a decision-making approach. https://app.cochat.ai/papers/10.1017/s0033291703008183
- The paper
- BYFORD, S., KNAPP, M., GREENSHIELDS, J., UKOUMUNNE, O. C., JONES, V., THOMPSON, S., TYRER, P., SCHMIDT, U., DAVIDSON, K., & ( POPMACT GROUP). (2003). Cost-effectiveness of brief cognitive behaviour therapy versus treatment as usual in recurrent deliberate self-harm: a decision-making approach. Psychological Medicine. https://doi.org/10.1017/s0033291703008183
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.